Globenewswire·2026-01-21 17:15Core Viewpoint - Smith+Nephew has completed the acquisition of Integrity Orthopaedics, enhancing its sports medicine shoulder repair business with advanced technologies for rotator cuff repair [1][6]. Company Overview - Smith+Nephew is a global medical technology company focused on the repair, regeneration, and replacement of soft and hard tissue, with annual sales of $5.8 billion in 2024 [9]. - The company operates in approximately 100 countries and employs around 17,000 people [9]. Acquisition Details - The acquisition of Integrity Orthopaedics strengthens Smith+Nephew's portfolio in the rotator cuff repair (RCR) market, which sees around 500,000 procedures annually in the US [5]. - Integrity Orthopaedics is known for its Tendon Seam™, a biomechanical RCR system aimed at reducing re-tear rates and improving patient outcomes [2][5]. Product Innovation - Tendon Seam™ features a novel repair stitch configuration with patented microanchors and continuous suture, designed to provide stronger repairs and accelerate patient recovery [3]. - Early clinical experiences indicate lower re-tear rates and shorter procedures compared to traditional methods, with the system receiving 510(k) clearance in 2023 [3][5]. Market Positioning - The Tendon Seam™ technology complements Smith+Nephew's existing REGENETEN Bioinductive Implant, creating a unique and differentiated RCR portfolio that combines biomechanical repair and biological augmentation [6]. - The company aims to leverage its commercial channels in the US to accelerate the adoption of Tendon Seam™ while building evidence for global adoption [7].